Table 2.

Intensive regimens for elderly AML

Intensive regimens for elderly AML

HOVON indicates Stichting Hemato-Oncologie voor Volwassenen Nederland; ED, early death; Ara-C, cytarabine; GO, gemtuzumab ozogamicin; MTZ, mitoxantrone; IL-2, interleukin-2; DAT, daunorubicin, cytarabine, 6-thioguanine; ATRA, tretinoin; ICE, idarubicin, cytarabine, etoposide; IE, idarubicin, etoposide; MICE, mitoxantrone, etoposide, cytarabine.

Close Modal

or Create an Account

Close Modal
Close Modal